Internal Medicine, Endocrinology, Diabetes, & Metabolism · Flemington, NJ
NPI
1770557837
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
9100 Wescott Dr, Suite 101
Flemington, NJ, 08822
Phone (908) 237-6900
Groups this clinician bills Medicare through
Medicare paid, 2024
$106K
2,137 services
Medicare patients, 2024
472
Average age 73
Drug cost, 2024
$4.1M
6,342 prescriptions
Company payments, 2025
$47K
From 35 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marc I Sandberg was code 99214 (office e&m - established), 753 times for 411 patients. In total Marc I Sandberg billed 2,137 services in 19 codes, and Medicare paid $106K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-12-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 753 | 411 | $99.35 | $75K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 633 | 378 | $13.45 | $8,516 |
| 83036 Blood Count | Office | 231 | 179 | $9.52 | $2,199 |
| 95251 Test - Miscellaneous | Office | 230 | 116 | $27.62 | $6,352 |
| 36415 Venipuncture Blood Collection | Office | 114 | 91 | $8.65 | $986 |
| 99204 Office E&M - New | Office | 51 | 51 | $128.10 | $6,533 |
| 99213 Office E&M - Established | Office | 24 | 23 | $72.93 | $1,750 |
| G0008 Administration of influenza virus vaccine | Office | 24 | 23 | $35.50 | $852 |
| 90662 Vaccine Product | Office | 20 | 19 | $64.81 | $1,296 |
| 82962 Clinical Chemistry | Office | 18 | 17 | $3.21 | $57.78 |
| 99215 Office E&M - Established | Office | 12 | 12 | $130.63 | $1,568 |
By year: 2022 $97K for 1,426 services; 2023 $91K for 1,394 services; 2024 $106K for 2,137 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 231 | 179 | $9.52 | $2,199 |
| 36415 Venipuncture Blood Collection | 114 | 91 | $8.65 | $986 |
| 82962 Clinical Chemistry | 18 | 17 | $3.21 | $57.78 |
Medicare prescription drug claims, 2024
In 2024, the drug Marc I Sandberg prescribed most often to Medicare patients was Ozempic (Semaglutide), with 486 prescriptions and refills. In total Marc I Sandberg wrote 6,342 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 486 | 724 | 80 | $661K |
| Metformin Hcl Generic | 428 | 1,146 | 118 | $4,220 |
| Synthroid Levothyroxine Sodium | 367 | 921 | 92 | $42K |
| Trulicity Dulaglutide | 321 | 474 | 68 | $455K |
| Mounjaro Tirzepatide | 318 | 393 | 56 | $403K |
| Unithroid Levothyroxine Sodium | 300 | 788 | 87 | $9,327 |
| Jardiance Empagliflozin | 293 | 521 | 58 | $295K |
| Atorvastatin Calcium Generic | 256 | 724 | 71 | $3,429 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 244 | 631 | 95 | $18K |
| Synjardy Xr Empagliflozin/Metformin Hcl | 196 | 388 | 42 | $213K |
| Tresiba Flextouch U-200 Insulin Degludec | 171 | 386 | 45 | $160K |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 163 | 261 | 42 | $226K |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 109 | 264 | 35 | $110K |
| Metformin Hcl Er Metformin Hcl | 101 | 261 | 31 | $1,321 |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 87 | 181 | 26 | $66K |
Brand drugs: 4,128 claims; generic drugs: 1,606 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marc I Sandberg $47K ($47K in general payments such as food, travel and fees) from 35 companies. The largest payer was Novo Nordisk Inc with $14K.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 31 | $14K |
| Lilly USA, LLC LLY | 25 | $12K |
| Sanofi-Aventis U.S. LLC SNY | 10 | $10K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $4,473 |
| Amneal Pharmaceuticals LLC AMRX | 5 | $2,814 |
| Recordati_rare_diseases_inc. | 11 | $2,145 |
| Corcept Therapeutics CORT | 11 | $177 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $175 |
| Dexcom, Inc. DXCM | 6 | $135 |
| Abbott Laboratories ABT | 5 | $115 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.